메뉴 건너뛰기




Volumn 31, Issue 5, 2012, Pages 534-536

Pneumococcal bacteremia in a vaccinated pediatric sickle cell disease population

Author keywords

Penicillin prophylaxis; Pneumococcal heptavalent vaccine; Pneumococcal polysaccharide vaccine

Indexed keywords

PENICILLIN G; PNEUMOCOCCUS VACCINE;

EID: 84860242785     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182480fed     Document Type: Article
Times cited : (25)

References (15)
  • 1
    • 0022628893 scopus 로고
    • Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial
    • Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med. 1986;314:1593-1599.
    • (1986) N Engl J Med , vol.314 , pp. 1593-1599
    • Gaston, M.H.1    Verter, J.I.2    Woods, G.3
  • 2
    • 0036693177 scopus 로고    scopus 로고
    • Streptococcus pneumoniae sepsis and meningitis during the penicillin prophylaxis era in children with sickle cell disease
    • Hord J, Byrd R, Stowe L, et al. Streptococcus pneumoniae sepsis and meningitis during the penicillin prophylaxis era in children with sickle cell disease. J Pediatr Hematol Oncol. 2002;24:470-472.
    • (2002) J Pediatr Hematol Oncol , vol.24 , pp. 470-472
    • Hord, J.1    Byrd, R.2    Stowe, L.3
  • 3
    • 0242298737 scopus 로고    scopus 로고
    • Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination
    • Adamkiewicz TV, Sarnaik S, Buchanan GR, et al. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. J Pediatr. 2003;143:438-444.
    • (2003) J Pediatr , vol.143 , pp. 438-444
    • Adamkiewicz, T.V.1    Sarnaik, S.2    Buchanan, G.R.3
  • 4
    • 0031893832 scopus 로고    scopus 로고
    • Compliance with penicillin prophylaxis in patients with sickle cell disease
    • Teach SJ, Lillis KA, Grossi M. Compliance with penicillin prophylaxis in patients with sickle cell disease. Arch Pediatr Adolesc Med. 1998;152: 274-278.
    • (1998) Arch Pediatr Adolesc Med , vol.152 , pp. 274-278
    • Teach, S.J.1    Lillis, K.A.2    Grossi, M.3
  • 5
    • 0035104269 scopus 로고    scopus 로고
    • Parental health beliefs and compliance with prophylactic penicillin administration in children with sickle cell disease
    • Elliott V, Morgan S, Day S, et al. Parental health beliefs and compliance with prophylactic penicillin administration in children with sickle cell disease. J Pediatr Hematol Oncol. 2001;23:112-116.
    • (2001) J Pediatr Hematol Oncol , vol.23 , pp. 112-116
    • Elliott, V.1    Morgan, S.2    Day, S.3
  • 6
    • 0018834933 scopus 로고
    • Antibody responses to polyvalent pneumococcal vaccine in infants with sickle cell anemia
    • Buchanan GR, Schiffman G. Antibody responses to polyvalent pneumococcal vaccine in infants with sickle cell anemia. J Pediatr. 1980;96: 264-266.
    • (1980) J Pediatr , vol.96 , pp. 264-266
    • Buchanan, G.R.1    Schiffman, G.2
  • 7
    • 0030357620 scopus 로고    scopus 로고
    • Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: Effects of continued penicillin prophylaxis
    • Bjornson AB, Falletta JM, Verter JI, et al. Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis. J Pediatr. 1996;129:828-835.
    • (1996) J Pediatr , vol.129 , pp. 828-835
    • Bjornson, A.B.1    Falletta, J.M.2    Verter, J.I.3
  • 8
    • 34249029657 scopus 로고    scopus 로고
    • Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine
    • Halasa NB, Shankar SM, Talbot TR, et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2007;44:1428-1433.
    • (2007) Clin Infect Dis , vol.44 , pp. 1428-1433
    • Halasa, N.B.1    Shankar, S.M.2    Talbot, T.R.3
  • 9
    • 40949107353 scopus 로고    scopus 로고
    • Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life
    • Adamkiewicz TV, Silk BJ, Howgate J, et al. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Pediatrics. 2008;121:562-569.
    • (2008) Pediatrics , vol.121 , pp. 562-569
    • Adamkiewicz, T.V.1    Silk, B.J.2    Howgate, J.3
  • 10
    • 84860250478 scopus 로고    scopus 로고
    • Clinical and Laboratory Standards Institute CLSI document M100-S21 Wayne, PA: Clinical and Laboratory Standards Institute
    • Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement. CLSI document M100-S21. Vol. 31, No. 1. Wayne, PA: Clinical and Laboratory Standards Institute; 2011.
    • (2011) Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement , vol.31 , Issue.1
  • 11
    • 0033869176 scopus 로고    scopus 로고
    • Policy statement: Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine and antibiotic prophylaxis
    • American Academy of Pediatrics. Committee on Infectious Diseases
    • American Academy of Pediatrics. Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine and antibiotic prophylaxis. Pediatrics. 2000;106:362-366.
    • (2000) Pediatrics , vol.106 , pp. 362-366
  • 12
    • 46249091929 scopus 로고    scopus 로고
    • Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem
    • Critchley IA, Jacobs MR, Brown SD, et al. Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem. Antimicrob Agents Chemother. 2008;52:2639-2643.
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 2639-2643
    • Critchley, I.A.1    Jacobs, M.R.2    Brown, S.D.3
  • 13
    • 79951580942 scopus 로고    scopus 로고
    • Increase in invasive Streptococcus pneumoniae infections in children with sickle cell disease since pneumococcal conjugate vaccine licensure
    • McCavit TL, Quinn CT, Techasaensiri C, et al. Increase in invasive Streptococcus pneumoniae infections in children with sickle cell disease since pneumococcal conjugate vaccine licensure. J Pediatr. 2011;158:505-507.
    • (2011) J Pediatr , vol.158 , pp. 505-507
    • McCavit, T.L.1    Quinn, C.T.2    Techasaensiri, C.3
  • 14
    • 84863338459 scopus 로고    scopus 로고
    • Hospitalization for invasive pneumococcal disease in a national sample of children with sickle cell disease before and after PCV7 licensure
    • McCavit TL, Xuan L, Zhang S, et al. Hospitalization for invasive pneumococcal disease in a national sample of children with sickle cell disease before and after PCV7 licensure. Pediatr Blood Cancer. 2012;58:945-949.
    • (2012) Pediatr Blood Cancer , vol.58 , pp. 945-949
    • McCavit, T.L.1    Xuan, L.2    Zhang, S.3
  • 15
    • 0028812672 scopus 로고
    • Discontinuing penicillin prophylaxis in children with sickle cell anemia
    • Prophylactic Penicillin Study II
    • Falletta JM, Woods GM, Verter JI, et al. Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II. J Pediatr. 1995;127:685-690.
    • (1995) J Pediatr , vol.127 , pp. 685-690
    • Falletta, J.M.1    Woods, G.M.2    Verter, J.I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.